Zaid Pardesi
CEO & ChairmanMr. Zaid Pardesi serves as Chief Executive Officer of Oaktree Acquisition Corp. III Life Sciences since July 2024, serves as its Director from January 6, 2025 and also serves as its Chairman. He serves as President and Chief Financial Officer at Oaktree Acquisition Corp. III since February 2021. Mr. Pardesi serves as Principal at The Cranemere Group Limited. From July 2019 to January 2021, he was Chief Financial Officer and Head of M&A at Oaktree Acquisition Corp. He served as Chief Financial Officer and Head of M&A of Oaktree Acquisition Corp. II since September 2020 until June 2022. He is a Senior Vice President within Oaktree’s Value Equities strategy. He has spent his career originating, acquiring and managing middle-market companies in the industrial, consumer and healthcare sectors, often-operating platforms as Chief Financial Officer. He serves as Managing Director at Oaktree Capital Management, L.P. Mr. Pardesi joined Oaktree in 2019 from The Cranemere Group, a global holding company, where he was a senior investment professional acquiring middle-market business. Prior thereto, he was an investor at H.I.G. Capital, where he co-founded and co-led the Chicago office and at AEA Investors in New York and London. He began his career at Bain & Company. Mr. Pardesi received an M.B.A. from The Wharton School at the University of Pennsylvania and a B.S. from Northwestern University, where he was a computer engineering and economics double major.
Positions
- Company NameOaktree Acquisition Corp. III Life SciencesStock CodeOACCPositionCEO & ChairmanRelated Securities
